In 2023, the standardized mortality rate for Alzheimer's disease in the U.S. stood at 34.2 units per hundred thousand men. From 2024 to 2028, forecasts indicate a gradual increase from 34.7 to 36.8 with an average compounded annual growth rate (CAGR) of 1.17%. Year-on-year increases show a modest but consistent rise, reflecting ongoing challenges in Alzheimer's disease management and prevention.
Future trends to watch for include advancements in medical research aimed at reducing mortality rates, policy changes in healthcare for aging populations, and the impact of early diagnosis and treatment on these projections.
